A: Obesity is a chronic disease, and weight loss isn't just about willpower. Prescription medication can reset your metabolism and break the cycle of obesity.

A: Many people are; they just did not tell you. About 7 million prescriptions are written every year in the US. Weight loss is never easy to talk about, so many people do not. 

Semaglutide and Tirzepatide are newer medications, so people without Diabetes are only starting to learn about them.

A: With Semaglutide, although some people see results immediately, you may only lose weight after 6-8 weeks of treatment. The dose needs to be slowly increased over the first 9-16 weeks. 

On Tirzepatide, it is common to see weight loss from the start of treatment with continued steady weight loss.

A: Initial consultation/comprehensive visit including a full lab panel and body composition analysis. Meet with one of our ReSet medical team specialists to review your medical history and weight loss goals. 

Treatment plan. We will create a personalized treatment plan based on your labs, goals, lifestyle needs, and body composition report and choose the best medication and diet plan for you.

On-going support. Monthly in office or telemed visits to manage your medication. Monthly training modules and Weight Loss Wednesdays webinars. Members-only resource center and text/call support to keep your weight loss on track. 

A: Our team of healthcare providers has over 30+ years of experience. We focus on wellness, not illness. Harvard-trained endocrinologists, diabetes educators, Dietitians, and nutritionists, work together to achieve weight loss. Medications are dispensed on-site or shipped to your home. We offer both in-office and tele-med appointments.

A: To understand how GLP-1 agonists work, it helps to understand how the naturally occurring GLP-1 hormone works. GLP-1 is a hormone that your small intestine makes. It has several roles, including:
Slowing stomach emptying: Slower digestion means that your body releases less glucose (sugar) from the food you eat into your bloodstream.
Increasing how full you feel after eating (satiety): GLP-1 affects areas of your brain that process hunger and satiety.
Triggering insulin release from your pancreas: Insulin is an essential hormone that allows your body to use the food you eat for energy. It lowers the amount of glucose (sugar) in your blood. If you don’t have enough insulin, your blood sugar increases, leading to diabetes.
Blocking glucagon secretion: Glucagon is a hormone your body uses to raise your blood sugar levels when necessary. So, GLP-1 prevents more glucose from going into your bloodstream. The satiety effect of GLP1-agonists reduces your food intake, appetite and hunger. These combined effects often result in weight loss.

A: Other weight loss places may make promises and guarantees, but instead of gimmicks, we prefer to let the science and results speak for themselves. Results depend on individuals, so come and find out what you can achieve.

On Semaglutide, once you reach the full dose at 9-16 weeks, it is typically a steady 1-3 pounds of weight loss a week. 

On Tirzepatide, it is common to see weight loss from the start of treatment with continued steady weight loss as the dosage is increased.

A: Semaglutide is newly approved for weight loss, but it has been approved and used to treat Type 2 Diabetes since 2017. This class of medications (similar to Ozempic, Wegovy, and Trulicity) has been approved since 2005. Semaglutide is also non-addictive and has no known severe or long-term side effects.

Tirzepatide (similar to Mounjaro) is approved for treating Diabetes and is currently on the fast track for FDA approval for weight loss.